APO Research
Talk to an analyst

APO RESEARCH · REPORT

CRO in Clinical Trials

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global CRO in Clinical Trials Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchCRO in Clinical Trials Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal CRO in Clinical Trials Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal CRO in Clinical Trials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CRO in Clinical Trials Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal CRO in Clinical Trials Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global CRO in Clinical Trials market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for CRO in Clinical Trials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for CRO in Clinical Trials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for CRO in Clinical Trials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for CRO in Clinical Trials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of CRO in Clinical Trials include Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, MedPace and Wuxi AppTec, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for CRO in Clinical Trials, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of CRO in Clinical Trials, also provides the revenue of main regions and countries. Of the upcoming market potential for CRO in Clinical Trials, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the CRO in Clinical Trials revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global CRO in Clinical Trials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for CRO in Clinical Trials revenue, projected growth trends, production technology, application and end-user industry.

CRO in Clinical Trials Segment by Company

Labcorp

IQVIA

Parexel

Syneos Health

PRA Health Sciences

PPD

ICON

MedPace

Wuxi AppTec

CRO in Clinical Trials Segment by Type

Phase I Trial

Phase II Trial

Phase III Trial

Phase IV Trial

CRO in Clinical Trials Segment by End User

Pharmaceutical

Bio-pharm

Others

CRO in Clinical Trials Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRO in Clinical Trials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CRO in Clinical Trials and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRO in Clinical Trials.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of CRO in Clinical Trials in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of CRO in Clinical Trials company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CRO in Clinical Trials revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global CRO in Clinical Trials Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Phase I Trial Major Player Table 3. Phase II Trial Major Player Table 4. Phase III Trial Major Player Table 5. Phase IV Trial Major Player Table 6. Global CRO in Clinical Trials Market Size Growth Rate by End User (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Major Player Table 8. Bio-pharm Major Player Table 9. Others Major Player Table 10. CRO in Clinical Trials Industry Trends Table 11. CRO in Clinical Trials Industry Drivers Table 12. CRO in Clinical Trials Industry Opportunities and Challenges Table 13. CRO in Clinical Trials Industry Restraints Table 14. Global CRO in Clinical Trials Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global CRO in Clinical Trials Market Size by Region (2021-2026) & (US$ Million) Table 16. Global CRO in Clinical Trials Market Share by Region (2021-2026) Table 17. Global CRO in Clinical Trials Market Size by Region (2027-2032) & (US$ Million) Table 18. Global CRO in Clinical Trials Market Share by Region (2027-2032) Table 19. Global CRO in Clinical Trials Revenue by Players (US$ Million) & (2021-2026) Table 20. Global CRO in Clinical Trials Revenue Market Share by Players (2021-2026) Table 21. Global CRO in Clinical Trials Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global CRO in Clinical Trials Key Players Headquarters & Area Served Table 23. Global CRO in Clinical Trials Players, Product Type & Application Table 24. Global CRO in Clinical Trials Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global CRO in Clinical Trials by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global CRO in Clinical Trials Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global CRO in Clinical Trials Revenue by Type (2021-2026) & (US$ Million) Table 29. Global CRO in Clinical Trials Revenue by Type (2027-2032) & (US$ Million) Table 30. Global CRO in Clinical Trials Revenue Market Share by Type (2021-2026) Table 31. Global CRO in Clinical Trials Revenue Market Share by Type (2027-2032) Table 32. Global CRO in Clinical Trials Revenue by End User 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global CRO in Clinical Trials Revenue by End User (2021-2026) & (US$ Million) Table 34. Global CRO in Clinical Trials Revenue by End User (2027-2032) & (US$ Million) Table 35. Global CRO in Clinical Trials Revenue Market Share by End User (2021-2026) Table 36. Global CRO in Clinical Trials Revenue Market Share by End User (2027-2032) Table 37. Labcorp Company Information Table 38. Labcorp Business Overview Table 39. Labcorp CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Labcorp CRO in Clinical Trials Product Portfolio Table 41. Labcorp Recent Development Table 42. IQVIA Company Information Table 43. IQVIA Business Overview Table 44. IQVIA CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. IQVIA CRO in Clinical Trials Product Portfolio Table 46. IQVIA Recent Development Table 47. Parexel Company Information Table 48. Parexel Business Overview Table 49. Parexel CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Parexel CRO in Clinical Trials Product Portfolio Table 51. Parexel Recent Development Table 52. Syneos Health Company Information Table 53. Syneos Health Business Overview Table 54. Syneos Health CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Syneos Health CRO in Clinical Trials Product Portfolio Table 56. Syneos Health Recent Development Table 57. PRA Health Sciences Company Information Table 58. PRA Health Sciences Business Overview Table 59. PRA Health Sciences CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. PRA Health Sciences CRO in Clinical Trials Product Portfolio Table 61. PRA Health Sciences Recent Development Table 62. PPD Company Information Table 63. PPD Business Overview Table 64. PPD CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. PPD CRO in Clinical Trials Product Portfolio Table 66. PPD Recent Development Table 67. ICON Company Information Table 68. ICON Business Overview Table 69. ICON CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. ICON CRO in Clinical Trials Product Portfolio Table 71. ICON Recent Development Table 72. MedPace Company Information Table 73. MedPace Business Overview Table 74. MedPace CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. MedPace CRO in Clinical Trials Product Portfolio Table 76. MedPace Recent Development Table 77. Wuxi AppTec Company Information Table 78. Wuxi AppTec Business Overview Table 79. Wuxi AppTec CRO in Clinical Trials Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Wuxi AppTec CRO in Clinical Trials Product Portfolio Table 81. Wuxi AppTec Recent Development Table 82. North America CRO in Clinical Trials Revenue by Type (2021-2026) & (US$ Million) Table 83. North America CRO in Clinical Trials Revenue by Type (2027-2032) & (US$ Million) Table 84. North America CRO in Clinical Trials Revenue by End User (2021-2026) & (US$ Million) Table 85. North America CRO in Clinical Trials Revenue by End User (2027-2032) & (US$ Million) Table 86. North America CRO in Clinical Trials Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America CRO in Clinical Trials Revenue by Country (2021-2026) & (US$ Million) Table 88. North America CRO in Clinical Trials Revenue by Country (US$ Million) & (2027-2032) Table 89. Europe CRO in Clinical Trials Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe CRO in Clinical Trials Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe CRO in Clinical Trials Revenue by End User (2021-2026) & (US$ Million) Table 92. Europe CRO in Clinical Trials Revenue by End User (2027-2032) & (US$ Million) Table 93. Europe CRO in Clinical Trials Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Europe CRO in Clinical Trials Revenue by Country (2021-2026) & (US$ Million) Table 95. Europe CRO in Clinical Trials Revenue by Country (US$ Million) & (2027-2032) Table 96. China CRO in Clinical Trials Revenue by Type (2021-2026) & (US$ Million) Table 97. China CRO in Clinical Trials Revenue by Type (2027-2032) & (US$ Million) Table 98. China CRO in Clinical Trials Revenue by End User (2021-2026) & (US$ Million) Table 99. China CRO in Clinical Trials Revenue by End User (2027-2032) & (US$ Million) Table 100. Asia CRO in Clinical Trials Revenue by Type (2021-2026) & (US$ Million) Table 101. Asia CRO in Clinical Trials Revenue by Type (2027-2032) & (US$ Million) Table 102. Asia CRO in Clinical Trials Revenue by End User (2021-2026) & (US$ Million) Table 103. Asia CRO in Clinical Trials Revenue by End User (2027-2032) & (US$ Million) Table 104. Asia CRO in Clinical Trials Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Asia CRO in Clinical Trials Revenue by Region (US$ Million) & (2021-2026) Table 106. Asia CRO in Clinical Trials Revenue by Region (US$ Million) & (2027-2032) Table 107. SAMEA CRO in Clinical Trials Revenue by Type (2021-2026) & (US$ Million) Table 108. SAMEA CRO in Clinical Trials Revenue by Type (2027-2032) & (US$ Million) Table 109. SAMEA CRO in Clinical Trials Revenue by End User (2021-2026) & (US$ Million) Table 110. SAMEA CRO in Clinical Trials Revenue by End User (2027-2032) & (US$ Million) Table 111. SAMEA CRO in Clinical Trials Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. SAMEA CRO in Clinical Trials Revenue by Country (2021-2026) & (US$ Million) Table 113. SAMEA CRO in Clinical Trials Revenue by Country (US$ Million) & (2027-2032) Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. CRO in Clinical Trials Image Figure 2. Global CRO in Clinical Trials Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global CRO in Clinical Trials Market Size Share 2021 VS 2025 VS 2032 Figure 4. Phase I Trial Image Figure 5. Phase II Trial Image Figure 6. Phase III Trial Image Figure 7. Phase IV Trial Image Figure 8. Global CRO in Clinical Trials Market Size Growth Rate by End User (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global CRO in Clinical Trials Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Image Figure 11. Bio-pharm Image Figure 12. Others Image Figure 13. Global CRO in Clinical Trials Market Size (US$ Million) & (2021-2032) Figure 14. Global CRO in Clinical Trials Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global CRO in Clinical Trials Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global CRO in Clinical Trials Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global CRO in Clinical Trials Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global CRO in Clinical Trials Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global CRO in Clinical Trials Revenue Market Share by Type (2021-2032) Figure 21. Global CRO in Clinical Trials Revenue by End User (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global CRO in Clinical Trials Revenue Market Share by End User (2021 VS 2025 VS 2032) Figure 23. Global CRO in Clinical Trials Revenue Market Share by End User (2021-2032) Figure 24. North America CRO in Clinical Trials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America CRO in Clinical Trials Revenue Share by Type (2021-2032) Figure 26. North America CRO in Clinical Trials Revenue Share by Application (2021-2032) Figure 27. North America CRO in Clinical Trials Revenue Share by Country (2021-2032) Figure 28. United States CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe CRO in Clinical Trials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe CRO in Clinical Trials Revenue Share by Type (2021-2032) Figure 33. Europe CRO in Clinical Trials Revenue Share by Application (2021-2032) Figure 34. Europe CRO in Clinical Trials Revenue Share by Country (2021-2032) Figure 35. Germany CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China CRO in Clinical Trials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China CRO in Clinical Trials Revenue Share by Type (2021-2032) Figure 45. China CRO in Clinical Trials Revenue Share by Application (2021-2032) Figure 46. Asia CRO in Clinical Trials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia CRO in Clinical Trials Revenue Share by Type (2021-2032) Figure 48. Asia CRO in Clinical Trials Revenue Share by Application (2021-2032) Figure 49. Asia CRO in Clinical Trials Revenue Share by Region (2021-2032) Figure 50. Japan CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA CRO in Clinical Trials Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA CRO in Clinical Trials Revenue Share by Type (2021-2032) Figure 58. SAMEA CRO in Clinical Trials Revenue Share by Application (2021-2032) Figure 59. SAMEA CRO in Clinical Trials Revenue Share by Country (2021-2032) Figure 60. Brazil CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt CRO in Clinical Trials Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Phase I Trial
  • Phase II Trial
  • Phase III Trial
  • Phase IV Trial
Applications
  • Pharmaceutical
  • Bio-pharm
  • Others
Companies covered
  • Labcorp
  • IQVIA
  • Parexel
  • Syneos Health
  • PRA Health Sciences
  • PPD
  • ICON
  • MedPace
  • Wuxi AppTec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 CRO in Clinical Trials Market by Type
  3. 1.2.1 Global CRO in Clinical Trials Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Phase I Trial
  5. 1.2.3 Phase II Trial
  6. 1.2.4 Phase III Trial
  7. 1.2.5 Phase IV Trial
  8. 1.3 CRO in Clinical Trials Market by End User
  9. 1.3.1 Global CRO in Clinical Trials Market Size by End User, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical
  11. 1.3.3 Bio-pharm
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 CRO in Clinical Trials Market Dynamics
  1. 2.1 CRO in Clinical Trials Industry Trends
  2. 2.2 CRO in Clinical Trials Industry Drivers
  3. 2.3 CRO in Clinical Trials Industry Opportunities and Challenges
  4. 2.4 CRO in Clinical Trials Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global CRO in Clinical Trials Market Perspective (2021-2032)
  2. 3.2 Global CRO in Clinical Trials Growth Trends by Region
  3. 3.2.1 Global CRO in Clinical Trials Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global CRO in Clinical Trials Market Size by Region (2021-2026)
  5. 3.2.3 Global CRO in Clinical Trials Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global CRO in Clinical Trials Revenue by Players
  2. 4.1.1 Global CRO in Clinical Trials Revenue by Players (2021-2026)
  3. 4.1.2 Global CRO in Clinical Trials Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global CRO in Clinical Trials Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global CRO in Clinical Trials Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global CRO in Clinical Trials Key Players Headquarters & Area Served
  7. 4.4 Global CRO in Clinical Trials Players, Product Type & Application
  8. 4.5 Global CRO in Clinical Trials Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global CRO in Clinical Trials Market CR5 and HHI
  11. 4.6.3 2025 CRO in Clinical Trials Tier 1, Tier 2, and Tier 3
5 CRO in Clinical Trials Market Size by Type
  1. 5.1 Global CRO in Clinical Trials Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global CRO in Clinical Trials Revenue by Type (2021-2032)
  3. 5.3 Global CRO in Clinical Trials Revenue Market Share by Type (2021-2032)
6 CRO in Clinical Trials Market Size by Application
  1. 6.1 Global CRO in Clinical Trials Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global CRO in Clinical Trials Revenue by Application (2021-2032)
  3. 6.3 Global CRO in Clinical Trials Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Labcorp
  2. 7.1.1 Labcorp Company Information
  3. 7.1.2 Labcorp Business Overview
  4. 7.1.3 Labcorp CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Labcorp CRO in Clinical Trials Product Portfolio
  6. 7.1.5 Labcorp Recent Developments
  7. 7.2 IQVIA
  8. 7.2.1 IQVIA Company Information
  9. 7.2.2 IQVIA Business Overview
  10. 7.2.3 IQVIA CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  11. 7.2.4 IQVIA CRO in Clinical Trials Product Portfolio
  12. 7.2.5 IQVIA Recent Developments
  13. 7.3 Parexel
  14. 7.3.1 Parexel Company Information
  15. 7.3.2 Parexel Business Overview
  16. 7.3.3 Parexel CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Parexel CRO in Clinical Trials Product Portfolio
  18. 7.3.5 Parexel Recent Developments
  19. 7.4 Syneos Health
  20. 7.4.1 Syneos Health Company Information
  21. 7.4.2 Syneos Health Business Overview
  22. 7.4.3 Syneos Health CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Syneos Health CRO in Clinical Trials Product Portfolio
  24. 7.4.5 Syneos Health Recent Developments
  25. 7.5 PRA Health Sciences
  26. 7.5.1 PRA Health Sciences Company Information
  27. 7.5.2 PRA Health Sciences Business Overview
  28. 7.5.3 PRA Health Sciences CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  29. 7.5.4 PRA Health Sciences CRO in Clinical Trials Product Portfolio
  30. 7.5.5 PRA Health Sciences Recent Developments
  31. 7.6 PPD
  32. 7.6.1 PPD Company Information
  33. 7.6.2 PPD Business Overview
  34. 7.6.3 PPD CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  35. 7.6.4 PPD CRO in Clinical Trials Product Portfolio
  36. 7.6.5 PPD Recent Developments
  37. 7.7 ICON
  38. 7.7.1 ICON Company Information
  39. 7.7.2 ICON Business Overview
  40. 7.7.3 ICON CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  41. 7.7.4 ICON CRO in Clinical Trials Product Portfolio
  42. 7.7.5 ICON Recent Developments
  43. 7.8 MedPace
  44. 7.8.1 MedPace Company Information
  45. 7.8.2 MedPace Business Overview
  46. 7.8.3 MedPace CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  47. 7.8.4 MedPace CRO in Clinical Trials Product Portfolio
  48. 7.8.5 MedPace Recent Developments
  49. 7.9 Wuxi AppTec
  50. 7.9.1 Wuxi AppTec Company Information
  51. 7.9.2 Wuxi AppTec Business Overview
  52. 7.9.3 Wuxi AppTec CRO in Clinical Trials Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Wuxi AppTec CRO in Clinical Trials Product Portfolio
  54. 7.9.5 Wuxi AppTec Recent Developments
8 North America
  1. 8.1 North America CRO in Clinical Trials Revenue (2021-2032)
  2. 8.2 North America CRO in Clinical Trials Revenue by Type (2021-2032)
  3. 8.2.1 North America CRO in Clinical Trials Revenue by Type (2021-2026)
  4. 8.2.2 North America CRO in Clinical Trials Revenue by Type (2027-2032)
  5. 8.3 North America CRO in Clinical Trials Revenue Share by Type (2021-2032)
  6. 8.4 North America CRO in Clinical Trials Revenue by End User (2021-2032)
  7. 8.4.1 North America CRO in Clinical Trials Revenue by End User (2021-2026)
  8. 8.4.2 North America CRO in Clinical Trials Revenue by End User (2027-2032)
  9. 8.5 North America CRO in Clinical Trials Revenue Share by End User (2021-2032)
  10. 8.6 North America CRO in Clinical Trials Revenue by Country
  11. 8.6.1 North America CRO in Clinical Trials Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America CRO in Clinical Trials Revenue by Country (2021-2026)
  13. 8.6.3 North America CRO in Clinical Trials Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe CRO in Clinical Trials Revenue (2021-2032)
  2. 9.2 Europe CRO in Clinical Trials Revenue by Type (2021-2032)
  3. 9.2.1 Europe CRO in Clinical Trials Revenue by Type (2021-2026)
  4. 9.2.2 Europe CRO in Clinical Trials Revenue by Type (2027-2032)
  5. 9.3 Europe CRO in Clinical Trials Revenue Share by Type (2021-2032)
  6. 9.4 Europe CRO in Clinical Trials Revenue by End User (2021-2032)
  7. 9.4.1 Europe CRO in Clinical Trials Revenue by End User (2021-2026)
  8. 9.4.2 Europe CRO in Clinical Trials Revenue by End User (2027-2032)
  9. 9.5 Europe CRO in Clinical Trials Revenue Share by End User (2021-2032)
  10. 9.6 Europe CRO in Clinical Trials Revenue by Country
  11. 9.6.1 Europe CRO in Clinical Trials Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe CRO in Clinical Trials Revenue by Country (2021-2026)
  13. 9.6.3 Europe CRO in Clinical Trials Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China CRO in Clinical Trials Revenue (2021-2032)
  2. 10.2 China CRO in Clinical Trials Revenue by Type (2021-2032)
  3. 10.2.1 China CRO in Clinical Trials Revenue by Type (2021-2026)
  4. 10.2.2 China CRO in Clinical Trials Revenue by Type (2027-2032)
  5. 10.3 China CRO in Clinical Trials Revenue Share by Type (2021-2032)
  6. 10.4 China CRO in Clinical Trials Revenue by End User (2021-2032)
  7. 10.4.1 China CRO in Clinical Trials Revenue by End User (2021-2026)
  8. 10.4.2 China CRO in Clinical Trials Revenue by End User (2027-2032)
  9. 10.5 China CRO in Clinical Trials Revenue Share by End User (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia CRO in Clinical Trials Revenue (2021-2032)
  2. 11.2 Asia CRO in Clinical Trials Revenue by Type (2021-2032)
  3. 11.2.1 Asia CRO in Clinical Trials Revenue by Type (2021-2026)
  4. 11.2.2 Asia CRO in Clinical Trials Revenue by Type (2027-2032)
  5. 11.3 Asia CRO in Clinical Trials Revenue Share by Type (2021-2032)
  6. 11.4 Asia CRO in Clinical Trials Revenue by End User (2021-2032)
  7. 11.4.1 Asia CRO in Clinical Trials Revenue by End User (2021-2026)
  8. 11.4.2 Asia CRO in Clinical Trials Revenue by End User (2027-2032)
  9. 11.5 Asia CRO in Clinical Trials Revenue Share by End User (2021-2032)
  10. 11.6 Asia CRO in Clinical Trials Revenue by Country
  11. 11.6.1 Asia CRO in Clinical Trials Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia CRO in Clinical Trials Revenue by Country (2021-2026)
  13. 11.6.3 Asia CRO in Clinical Trials Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA CRO in Clinical Trials Revenue (2021-2032)
  2. 12.2 SAMEA CRO in Clinical Trials Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA CRO in Clinical Trials Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA CRO in Clinical Trials Revenue by Type (2027-2032)
  5. 12.3 SAMEA CRO in Clinical Trials Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA CRO in Clinical Trials Revenue by End User (2021-2032)
  7. 12.4.1 SAMEA CRO in Clinical Trials Revenue by End User (2021-2026)
  8. 12.4.2 SAMEA CRO in Clinical Trials Revenue by End User (2027-2032)
  9. 12.5 SAMEA CRO in Clinical Trials Revenue Share by End User (2021-2032)
  10. 12.6 SAMEA CRO in Clinical Trials Revenue by Country
  11. 12.6.1 SAMEA CRO in Clinical Trials Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA CRO in Clinical Trials Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA CRO in Clinical Trials Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst